BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33040406)

  • 1. Association of homozygous variants of STING1 with outcome in human cervical cancer.
    Lubbers JM; Koopman B; de Klerk-Sluis JM; van Rooij N; Plat A; Pijper H; Koopman T; van Hemel BM; Hollema H; Wisman B; Nijman HW; de Bruyn M
    Cancer Sci; 2021 Jan; 112(1):61-71. PubMed ID: 33040406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires' disease in humans.
    Ruiz-Moreno JS; Hamann L; Shah JA; Verbon A; Mockenhaupt FP; Puzianowska-Kuznicka M; Naujoks J; Sander LE; Witzenrath M; Cambier JC; Suttorp N; Schumann RR; Jin L; Hawn TR; Opitz B;
    PLoS Pathog; 2018 Jan; 14(1):e1006829. PubMed ID: 29298342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Homozygous Variants in the STING-Encoding
    Nissen SK; Pedersen JG; Helleberg M; Kjær K; Thavachelvam K; Obel N; Tolstrup M; Jakobsen MR; Mogensen TH
    J Immunol; 2018 May; 200(10):3372-3382. PubMed ID: 29632140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer.
    Kol A; Lubbers JM; Terwindt ALJ; Workel HH; Plat A; Wisman GBA; Bart J; Nijman HW; De Bruyn M
    Oncoimmunology; 2021 Jun; 10(1):1936391. PubMed ID: 34178428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response.
    Shi F; Su J; Wang J; Liu Z; Wang T
    Mol Cell Biochem; 2021 Feb; 476(2):1015-1024. PubMed ID: 33141310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
    Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides.
    Yi G; Brendel VP; Shu C; Li P; Palanathan S; Cheng Kao C
    PLoS One; 2013; 8(10):e77846. PubMed ID: 24204993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Loss of Responsiveness to Exogenous but Not Endogenous Cyclic-Dinucleotides in Mice Expressing STING-R231H.
    Walker MM; Kim S; Crisler WJ; Nguyen K; Lenz LL; Cambier JC; Getahun A
    Front Immunol; 2020; 11():238. PubMed ID: 32153571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between susceptibility loci in cGAS-STING pathway, MHC gene and HPV infection on the risk of cervical precancerous lesions in Chinese population.
    Xiao D; Huang W; Ou M; Guo C; Ye X; Liu Y; Wang M; Zhang B; Zhang N; Huang S; Zang J; Zhou Z; Wen Z; Zeng C; Wu C; Huang C; Wei X; Yang G; Jing C
    Oncotarget; 2016 Dec; 7(51):84228-84238. PubMed ID: 27705945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The common H232 STING allele shows impaired activities in DNA sensing, susceptibility to viral infection, and in monocyte cell function, while the HAQ variant possesses wild-type properties.
    Froechlich G; Finizio A; Napolano A; Amiranda S; De Chiara A; Pagano P; Mallardo M; Leoni G; Zambrano N; Sasso E
    Sci Rep; 2023 Nov; 13(1):19541. PubMed ID: 37945588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis.
    Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
    J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
    Ni H; Zhang H; Li L; Huang H; Guo H; Zhang L; Li C; Xu JX; Nie CP; Li K; Zhang X; Xia X; Li J
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36126994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
    Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
    Front Immunol; 2021; 12():795401. PubMed ID: 35046953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cGAS/STING Pathway Detects Streptococcus pneumoniae but Appears Dispensable for Antipneumococcal Defense in Mice and Humans.
    Ruiz-Moreno JS; Hamann L; Jin L; Sander LE; Puzianowska-Kuznicka M; Cambier J; Witzenrath M; Schumann RR; Suttorp N; Opitz B
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263110
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.
    Zou SS; Qiao Y; Zhu S; Gao B; Yang N; Liu YJ; Chen J
    Pharmacol Res; 2021 Apr; 166():105514. PubMed ID: 33631336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Abnormal Elevations in IFIT3 With Overactive Cyclic GMP-AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes.
    Wang J; Dai M; Cui Y; Hou G; Deng J; Gao X; Liao Z; Liu Y; Meng Y; Wu L; Yao C; Wang Y; Qian J; Guo Q; Ding H; Qu B; Shen N
    Arthritis Rheumatol; 2018 Dec; 70(12):2036-2045. PubMed ID: 29806091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UXT attenuates the CGAS-STING1 signaling by targeting STING1 for autophagic degradation.
    Pan M; Yin Y; Hu T; Wang X; Jia T; Sun J; Wang Q; Meng W; Zhu J; Dai C; Hu H; Wang C
    Autophagy; 2023 Feb; 19(2):440-456. PubMed ID: 35543189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
    Mekers VE; Kho VM; Ansems M; Adema GJ
    Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.